Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes Research and Clinical Practice | Added Oct 19, 2021

Evaluating kidney and heart benefits of SGLT2 inhibitors for patients with diabetes and kidney disease

This review looked at SGLT2 inhibitor medications for people with both type 2 diabetes (T2D) and chronic kidney disease (CKD). It found that SGLT2 inhibitors reduced worsening of the kidneys for these patients.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Journal of Diabetes and its Complications | Added Oct 16, 2021

How beneficial are foot-ankle flexibility and resistance exercises for preventing foot diabetic ulcer recurrence?

This study assessed the effect of foot-ankle flexibility and resistance exercises in the prevention and recurrence of plantar foot-diabetic ulcers. The authors concluded that foot-ankle flexibility and resistance exercises can reduce the recurrence of plantar foot-diabetic ulcers and improve diabetic neuropathy (DN; nerve damage) and walking speed.

icon
rheumatoid arthritis | Research | 10 pages | source: Scientific reports | Added Oct 11, 2021

Do biologics increase the risk of blood clots in patients with rheumatoid arthritis?

This study looked at the risk of blood clots in patients with rheumatoid arthritis (RA) treated with biologics. It found that there was no significant increase in the risk of blood clots with biologics compared to other RA treatments.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: JAMA network open | Added Oct 09, 2021

How effective is a new macrophage-regulating drug for wound healing in patients with diabetic foot ulcers?

This study compared the therapeutic benefit of topically applied ON101 (Fespixon) cream to an absorbent dressing (Hydrofiber; ConvaTec Ltd) on wound healing in patients with chronic diabetic foot ulcers (DFUs). The authors concluded that the therapeutic effectiveness of ON101 treatment of DFUs was better compared to absorbent dressing.

icon
rheumatoid arthritis | Research | 10 pages | source: Annals of the rheumatic diseases | Added Oct 09, 2021

Is there a relationship between fatigue and disease activity in patients with early rheumatoid arthritis?

This study investigated the occurrence of fatigue (tiredness) in patients with early rheumatoid arthritis (RA) and identified predictors of fatigue after 24 months. The data showed that patients with early disease remission had a rapid, sustained reduction in fatigue and that low disease activity at diagnosis predicted a higher risk of fatigue at 24 months.

icon
icon
rheumatoid arthritis | Research | Treatment | 10 pages | source: Arthritis Research & Therapy | Added Oct 05, 2021

Is peficitinib an effective treatment for rheumatoid arthritis?

This study looked at the use of peficitinib (Smyraf) for the treatment of rheumatoid arthritis (RA) from the perspective of patients and their doctors. It found that peficitinib improved symptoms of RA and led to increased ability to work and carry out daily activities compared to placebo.

icon
rheumatoid arthritis | Research | 10 pages | source: PLOS ONE | Added Oct 03, 2021

Risk factors for fragility fractures in patients with rheumatoid arthritis.

This study explored the risk factors for fragility fractures in patients with rheumatoid arthritis (RA). The authors concluded that aging, disease-related factors, and previous fracture history are important risk factors for fragility fractures in these patients.

icon
icon
rheumatoid arthritis | Research | Lifestyle | 10 pages | source: PLOS ONE | Added Sep 26, 2021

Can diet influence depression among patients with rheumatoid arthritis?

This study investigated the relationships among depression and anxiety, diet, and disease activity or physical function in patients with rheumatoid arthritis (RA). The data showed that there was a relationship between depression and lower fish intake frequency in these patients. 

icon
diabetes mellitus | Research | 10 pages | source: Diabetes, Obesity and Metabolism | Added Sep 07, 2021

Does canagliflozin reduce the risk of hospitalization in patients with type 2 diabetes?

This study looked at the effect of canagliflozin (Invokana) on hospitalization occurrence in patients with type 2 diabetes (T2D). It found that patients treated with canagliflozin were less likely to be admitted to the hospital than patients treated with placebo. 

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Nature Medicine | Added Sep 05, 2021

Is closed-loop glucose control an effective treatment for patients with type 2 diabetes with serious kidney disease?

This study looked at the use of closed-loop glucose control treatment for patients with type 2 diabetes (T2D) requiring dialysis. It found that compared to standard insulin therapy, closed-loop glucose control led to improved glucose control in these patients. 

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?